<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7428924\results\search\testTrace\results.xml">
  <result pre="cited. Abstract Introduction: COVID-19 is the disease caused by an" exact="infection" post="of the SARS-CoV-2 virus, previously known as 2019 Novel"/>
  <result pre="of this study is to retreive published papers about COVID-19" exact="infection" post="deposited in PubMed data base and analyzed current results"/>
  <result pre="investigations regarding morbidity and mortality rates as consequences of COVID-19" exact="infection" post="and opinions of experts about treatment of afected patients"/>
  <result pre="as consequences of COVID-19 infection and opinions of experts about" exact="treatment" post="of afected patients with COVID-19 who have Cardiovascular diseases"/>
  <result pre="against COVID-19 is already produced and being in phases of" exact="testing" post="in praxis in treatment of COVID-19 at affected patients,"/>
  <result pre="produced and being in phases of testing in praxis in" exact="treatment" post="of COVID-19 at affected patients, but the opinions of"/>
  <result pre="most important dilemmas about all aspects of CVDs, including etipathogenesis," exact="treatment" post="with current drugs and use of potential discovered vaccines"/>
  <result pre="Guidelines 1. INTRODUCTION COVID-19 is the disease caused by an" exact="infection" post="of the SARS-CoV-2 virus, first identified in the city"/>
  <result pre="spread when an infected person coughs or sneezes. Respiratory virus" exact="infection" post="is a major source of global pandemics as a"/>
  <result pre="(including route of infection, viral evolution, epidemic dynamics, appropriate anti-viral" exact="treatment" post="and strategies for disease control) remain. Since there is"/>
  <result pre="vaccine, a rigorous epidemiological measure was first taken. The largest" exact="quarantine" post="in history was made, between 50 and 60 million"/>
  <result pre="(2-4). CVDs may become unstable in the setting of viral" exact="infection" post="as a consequence of imbalance between infection-induced increasing in"/>
  <result pre="31st, 2020, 390.423 persons worldwide died as consequences of COVID-19" exact="infection" post="and total number of infected people was 6,647.258 citizens."/>
  <result pre="2. THE CARDIOVASCULAR DISEASES (CVD) IN THE COVID-19 ERA COVID-19" exact="infection" post="is caused by a new beta-coronavirus, which the WHO"/>
  <result pre="7.2%, 8.7%, and 16.7% of patients, respectively (1), with higher" exact="prevalence" post="amongst patients requiring intensive care. Initially, the main complications"/>
  <result pre="high mortality (9). If patients already suffer from heart failure," exact="infection" post="with COVID-19 leads to worsening their health condition and"/>
  <result pre="is unwanted and one of the most spectacular moments during" exact="treatment" post="with CAR-T cells. This method consists of injecting T"/>
  <result pre="angiotensin II antagonists (ARBs) are first-line drugs used in the" exact="treatment" post="of hypertension, cardiac decompensation, after a myocardial infarction and"/>
  <result pre="of 60 develop hypertension) and at the same time the" exact="prevalence" post="of hypertension increases sharply in very old people. The"/>
  <result pre="every patient. Suppressing the immune system when the body fights" exact="infection" post="can lead to serious side effects and increase the"/>
  <result pre="to serious side effects and increase the risk of secondary" exact="infection" post="(19). In severe forms of COVID-19, Chinese doctors in"/>
  <result pre="and significantly increase the chances of these patients surviving. Effective" exact="treatment" post="of a cytokine storm would be the fastest response"/>
  <result pre="which is the most suitable and most appropriate in the" exact="treatment" post="of COVID-19 (20). Under the auspices of the World"/>
  <result pre="the real role and importance of Remdesivir is in the" exact="treatment" post="of COVID-19. There are currently 5 other studies with"/>
  <result pre="ORB International, in Europe in early April, 2020, while the" exact="infection" post="was still on the rise, show that resistance to"/>
  <result pre="family practitioners, epidemiologists, etc) with special preventive measures regarding COVID-19" exact="infection" post="(1). The severity of the primary respiratory syndrome and"/>
  <result pre="in critically ill ICU patients with COVID-19Thrombosis Research202019114514710.1016/j.thromres.2020.04.01332291094 8.VargaZFlammerAJSteigerPHabereckerMEndothelial cell" exact="infection" post="and endotheliitis in COVID-19Lancet20203951417141832325026 9.ChenTWuDChenDClinical characteristics of 113 deceased"/>
  <result pre="Treatments for Coronavirus Di-sease 2019 (COVID-19)A Review. JAMA202010.1001/jama.2020.6019 17.XuXet al.Effective" exact="treatment" post="of severe COVID-19 patients with tocilizumabPNAS2020117109701097510.1073/pnas.200561511732350134 18.WuDYangXOTH17 responses in"/>
 </snippets>
</snippetsTree>
